CVN-293

N/A

Report date: 2023/09/25 11:51:37
NME

Base Information

Drug NameCVN-293
Drug Alias NameCVN293CVN-293
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel subfamily K member 13 inhibitors
TargetsPotassium channel subfamily K member 13
Therapy Area/IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCerevance LLC
China Registration ClassN/A

Develop Information

Active CompaniesCerevance LtdCerevance LLC
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A